Reduction in levels of triidothyronine following the first stage of the Norwood reconstruction for hypoplastic left heart syndrome

被引:11
作者
Mainwaring, RD
Healy, RM
Meier, FA
Nelson, JC
Norwood, WI
机构
[1] Alfred I Dupont Hosp Children, Nemours Cardiac Ctr, Wilmington, DE 19899 USA
[2] Alfred I Dupont Hosp Children, Dept Pathol, Wilmington, DE 19899 USA
[3] Quest Diagnost Nichols Inst, San Juan Capistrano, CA USA
关键词
triiodothyronine; thyroid hormone; hypoplastic left heart; cardiopulmonary bypass;
D O I
10.1017/S1047951101000324
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Thyroid hormone has important effects on cardiovascular performance. This study was performed to evaluate the changes in levels of triiodothyronine following the first stage of reconstruction for hypoplastic left heart syndrome. Methods. We enrolled 14 newborns with hypoplastic left heart syndrome scheduled for first stage reconstruction, Blood samples were obtained pre-, intra-, and post-operatively. Levels of free and total triiodothyronine were determined by radioimmunoassay. Statistical comparison was performed using Wilcoxon's signed rank test. Results: The levels of free triiodothyronine decreased from a baseline of 355 +/- 31 pg/dl to 205 +/- 21 pg/dl upon the institution of bypass, and declined to a level of 135 +/- 9 pg/dl at 24 hours postoperatively, Similarly, levels of total triiodothyronine decreased from 101 +/- 15 ng/dl to 65 +/- 4 ng/dl upon the institution of bypass, and continued to decline during the first 24 hours postoperatively. Levels of free and total triiodothyronine had returned to baseline by the fifth postoperative day. Conclusions: The data demonstrate significant decreases in levels of free and total triiodothyronine during the early postoperative period. These changes in levels of thyroid hormone may have adverse effects on cardiac function during this phase of recovery.
引用
收藏
页码:295 / 300
页数:6
相关论文
共 30 条
[1]  
Bando K, 1996, ANN THORAC SURG, V62, P70, DOI 10.1016/0003-4975(96)00251-2
[2]   CIRCADIAN AND PULSATILE THYROTROPIN SECRETION IN EUTHYROID MAN UNDER THE INFLUENCE OF THYROID-HORMONE AND GLUCOCORTICOID ADMINISTRATION [J].
BRABANT, G ;
BRABANT, A ;
RANFT, U ;
OCRAN, K ;
KOHRLE, J ;
HESCH, RD ;
MUHLEN, AV .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (01) :83-88
[3]  
BREMNER WF, 1978, J THORAC CARDIOV SUR, V75, P392
[4]   THYROID-HORMONE CHANGES AFTER CARDIOVASCULAR-SURGERY AND CLINICAL IMPLICATIONS [J].
CHU, SH ;
HUANG, TS ;
HSU, RB ;
WANG, SS ;
WANG, CJ .
ANNALS OF THORACIC SURGERY, 1991, 52 (04) :791-796
[5]   CARDIAC-FUNCTION IN THYROID-DISEASE - CLINICAL-FEATURES AND MANAGEMENT CONSIDERATIONS [J].
DILLMANN, WH .
ANNALS OF THORACIC SURGERY, 1993, 56 (01) :S9-S15
[6]  
DiPierro FV, 1996, ANN THORAC SURG, V62, P662
[7]   Hemi-Fontan procedure for hypoplastic left heart syndrome: Outcome and suitability for Fontan [J].
Douglas, WI ;
Goldberg, CS ;
Mosca, RS ;
Law, IH ;
Bove, EL .
ANNALS OF THORACIC SURGERY, 1999, 68 (04) :1361-1367
[8]   An institutional experience with second- and third-stage palliative procedures for hypoplastic left heart syndrome: The impact of the bidirectional cavopulmonary shunt [J].
Forbess, JM ;
Cook, N ;
Serraf, A ;
Burke, RP ;
Mayer, JE ;
Jonas, RA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (03) :665-670
[9]   MANAGEMENT OF HYPOPLASTIC LEFT-HEART SYNDROME IN A CONSORTIUM OF UNIVERSITY HOSPITALS [J].
GUTGESELL, HP ;
MASSARO, TA .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (11) :809-811
[10]  
IANNETTONI MD, 1994, J THORAC CARDIOV SUR, V107, P934